OpenURL Connection Search

Select item for more details and to access through your institution.

A nomogram incorporating Ki67 to predict survival of acral melanoma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 14, p. 13077, doi. 10.1007/s00432-023-05127-w
By:
- Du, Yu;
- Li, Caili;
- Mao, Lili;
- Wei, Xiaoting;
- Bai, Xue;
- Chi, Zhihong;
- Cui, Chuanliang;
- Sheng, Xinan;
- Lian, Bin;
- Tang, Bixia;
- Wang, Xuan;
- Yan, Xieqiao;
- Li, Siming;
- Zhou, Li;
- Guo, Jun;
- Si, Lu
Publication type:
Article
Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.
Published in:
Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 9, p. 2731, doi. 10.1007/s00432-021-03563-0
By:
- Wang, Yang;
- Lian, Bin;
- Si, Lu;
- Chi, ZhiHong;
- Sheng, XiNan;
- Wang, Xuan;
- Mao, LiLi;
- Tang, BiXia;
- Li, SiMing;
- Yan, XieQiao;
- Bai, Xue;
- Zhou, Li;
- Cui, ChuanLiang;
- Guo, Jun
Publication type:
Article
Analysis of TSC1 mutation spectrum in mucosal melanoma.
Published in:
Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 2, p. 257, doi. 10.1007/s00432-017-2550-z
By:
- Ma, Meng;
- Dai, Jie;
- Xu, Tianxiao;
- Yu, Sifan;
- Yu, Huan;
- Tang, Huan;
- Yan, Junya;
- Wu, Xiaowen;
- Yu, Jiayi;
- Chi, Zhihong;
- Si, Lu;
- Cui, Chuanliang;
- Sheng, Xinan;
- Kong, Yan;
- Guo, Jun
Publication type:
Article
Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients.
Published in:
Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0693-2
By:
- Tang, Bixia;
- Yan, Xieqiao;
- Sheng, Xinan;
- Si, Lu;
- Cui, Chuanliang;
- Kong, Yan;
- Mao, Lili;
- Lian, Bin;
- Bai, Xue;
- Wang, Xuan;
- Li, Siming;
- Zhou, Li;
- Yu, Jiayi;
- Dai, Jie;
- Wang, Kai;
- Hu, Jinwei;
- Dong, Lihou;
- Song, Haifeng;
- Wu, Hai;
- Feng, Hui
Publication type:
Article
Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.
Published in:
Journal of Hematology & Oncology, 2018, v. 11, p. 1, doi. 10.1186/s13045-017-0548-2
By:
- Yu, Jiayi;
- Wu, Xiaowen;
- Yan, Junya;
- Yu, Huan;
- Xu, Longwen;
- Chi, Zhihong;
- Sheng, Xinan;
- Si, Lu;
- Cui, Chuanliang;
- Dai, Jie;
- Ma, Meng;
- Xu, Tianxiao;
- Kong, Yan;
- Guo, Jun
Publication type:
Article
Systemic Therapy in Patients With Metastatic Xp11.2 Translocation Renal Cell Carcinoma.
Published in:
Clinical Genitourinary Cancer, 2022, v. 20, n. 4, p. 354, doi. 10.1016/j.clgc.2022.03.005
By:
- Xieqiao Yan;
- Li Zhou;
- Siming Li;
- Xiaowen Wu;
- Chuanliang Cui;
- Zhihong Chi;
- Lu Si;
- Yan kong;
- Bixia Tang;
- Caili Li;
- Lili Mao;
- Xuan Wang;
- Bin Lian;
- Xue Bai;
- Jie Dai;
- Jun Guo;
- Xinan Sheng
Publication type:
Article
ASO Visual Abstract: An Evidence-Based Staging System for Mucosal Melanoma: a Proposal.
Published in:
2022
By:
- Cui, ChuanLiang;
- Lian, Bin;
- Zhang, XiaoShi;
- Wu, Di;
- Li, Ke;
- Si, Lu;
- Yang, Yue;
- Tian, Hui;
- Zhou, Li;
- Chi, ZhiHong;
- Sheng, XiNan;
- Kong, Yan;
- Mao, LiLi;
- Wang, Xuan;
- Bai, Xue;
- Yan, XieQiao;
- Li, SiMing;
- Dai, Jie;
- Tang, BiXia;
- Wei, Xiaoting
Publication type:
Abstract
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 8, p. 5221, doi. 10.1245/s10434-022-11670-6
By:
- Cui, ChuanLiang;
- Lian, Bin;
- Zhang, XiaoShi;
- Wu, Di;
- Li, Ke;
- Si, Lu;
- Yang, Yue;
- Tian, Hui;
- Zhou, Li;
- Chi, ZhiHong;
- Sheng, XiNan;
- Kong, Yan;
- Mao, LiLi;
- Wang, Xuan;
- Bai, Xue;
- Yan, XieQiao;
- Li, SiMing;
- Dai, Jie;
- Tang, BiXia;
- Wei, Xiaoting
Publication type:
Article
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 9, p. 3478, doi. 10.1245/s10434-020-08418-5
By:
- Wei, Xiaoting;
- Wu, Di;
- Li, Hang;
- Zhang, Rui;
- Chen, Yu;
- Yao, Hong;
- Chi, Zhihong;
- Sheng, Xinan;
- Cui, Chuanliang;
- Bai, Xue;
- Qi, Zhonghui;
- Li, Ke;
- Lan, Shijie;
- Chen, Lizhu;
- Guo, Rui;
- Yao, Xinyu;
- Mao, Lili;
- Lian, Bin;
- Kong, Yan;
- Dai, Jie
Publication type:
Article
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 8, p. 2184, doi. 10.1245/s10434-018-6503-9
By:
- Cui, ChuanLiang;
- Lian, Bin;
- Zhou, Li;
- Song, Xin;
- Zhang, XiaoShi;
- Wu, Di;
- Chi, ZhiHong;
- Si, Lu;
- Sheng, XiNan;
- Kong, Yan;
- Tang, BiXia;
- Mao, LiLi;
- Wang, Xuan;
- Li, SiMing;
- Dai, Jie;
- Yan, XieQiao;
- Bai, Xue;
- Balch, Charles M.;
- Guo, Jun
Publication type:
Article
miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1190-3
By:
- Tang, Huan;
- Ma, Meng;
- Dai, Jie;
- Cui, Chuanliang;
- Si, Lu;
- Sheng, Xinan;
- Chi, Zhihong;
- Xu, Longwen;
- Yu, Sifan;
- Xu, Tianxiao;
- Yan, Junya;
- Yu, Huan;
- Yang, Lu;
- Kong, Yan;
- Guo, Jun
Publication type:
Article
Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.
Published in:
2020
By:
- Sheng, Xinan;
- Jin, Jie;
- He, Zhisong;
- Huang, Yiran;
- Zhou, Aiping;
- Wang, Jinwan;
- Ren, Xiubao;
- Ye, Dingwei;
- Zhang, Xu;
- Qin, Shukui;
- Zhou, Fangjian;
- Wang, Binhui;
- Guo, Jun
Publication type:
journal article
Nanosecond Pulsed Electric Fields Enhance the Anti-tumour Effects of the mTOR Inhibitor Everolimus against Melanoma.
Published in:
Scientific Reports, 2017, p. 39597, doi. 10.1038/srep39597
By:
- Dai, Jie;
- Wu, Shan;
- Kong, Yan;
- Chi, Zhihong;
- Si, Lu;
- Sheng, Xinan;
- Cui, Chuanliang;
- Fang, Jing;
- Zhang, Jue;
- Guo, Jun
Publication type:
Article
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical Studies.
Published in:
Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.747416
By:
- Tian, Hui;
- Wang, Xuan;
- Lian, Bin;
- Yan, Xieqiao;
- Si, Lu;
- Chi, Zhihong;
- Sheng, Xinan;
- Kong, Yan;
- Mao, Lili;
- Bai, Xue;
- Tang, Bixia;
- Li, Siming;
- Zhou, Li;
- Cui, Chuanliang;
- Guo, Jun
Publication type:
Article
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.
Published in:
Oncology Research, 2019, v. 27, n. 4, p. 495, doi. 10.3727/096504018X15331163433914
By:
- Xiaoting Wei;
- Lili Mao;
- Zhihong Chi;
- Xinan Sheng;
- Chuanliang Cui;
- Yan Kong;
- Jie Dai;
- Xuan Wang;
- Siming Li;
- Bixia Tang;
- Bin Lian;
- Xieqiao Yan;
- Xue Bai;
- Li Zhouaa;
- Jun Guo;
- Lu Si
Publication type:
Article
Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma.
Published in:
NPJ Genomic Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41525-021-00169-w
By:
- Cui, Chuanliang;
- Xu, Canqiang;
- Yang, Wenxian;
- Chi, Zhihong;
- Sheng, Xinan;
- Si, Lu;
- Xie, Yihong;
- Yu, Jinyu;
- Wang, Shun;
- Yu, Rongshan;
- Guo, Jun;
- Kong, Yan
Publication type:
Article
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapy.
Published in:
British Journal of Dermatology, 2023, v. 188, n. 1, p. 112, doi. 10.1093/bjd/ljac005
By:
- Zhou, Li;
- Shao, Lizhi;
- Gao, Shunyu;
- Cui, Chuanliang;
- Chi, Zhihong;
- Sheng, Xinan;
- Tang, Bixia;
- Mao, Lili;
- Lian, Bin;
- Yan, Xieqiao;
- Wang, Xuan;
- Bai, Xue;
- Li, Siming;
- Guo, Jun;
- Si, Lu
Publication type:
Article
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10473-y
By:
- Cui, Chuanliang;
- Chen, Yu;
- Luo, Zhiguo;
- Zou, Zhengyun;
- Jiang, Yu;
- Pan, Hongming;
- Fan, Qingxia;
- Zhao, Jianfu;
- Xu, Qing;
- Jiang, Renbing;
- Wang, Xuan;
- Ma, Taiyang;
- Guo, Zhen;
- Si, Lu;
- Chi, Zhihong;
- Sheng, Xinan;
- Dou, Yiwei;
- Tan, Qian;
- Wu, Di;
- Guo, Jun
Publication type:
Article
A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.
Published in:
Molecular Therapy, 2013, v. 21, n. 7, p. 1456, doi. 10.1038/mt.2013.79
By:
- Cui, Chuanliang;
- Mao, Lili;
- Chi, Zhihong;
- Si, Lu;
- Sheng, Xinan;
- Kong, Yan;
- Li, Siming;
- Lian, Bin;
- Gu, Kangsheng;
- Tao, Min;
- Song, Xin;
- Lin, Tongyu;
- Ren, Xiubao;
- Qin, Shukui;
- Guo, Jun
Publication type:
Article
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa Trial.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.720044
By:
- Mao, Lili;
- Ding, Ya;
- Bai, Xue;
- Sheng, Xinan;
- Dai, Jie;
- Chi, Zhihong;
- Cui, Chuanliang;
- Kong, Yan;
- Fan, Yun;
- Xu, Yanjun;
- Wang, Xuan;
- Tang, Bixia;
- Lian, Bin;
- Yan, Xieqiao;
- Li, Siming;
- Zhou, Li;
- Wei, Xiaoting;
- Li, Caili;
- Guo, Jun;
- Zhang, Xiaoshi
Publication type:
Article
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy— Ad hoc Analyses of Pooled Data From Two Clinical Trials.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.639085
By:
- Bai, Xue;
- Dai, Jie;
- Li, Caili;
- Cui, Chuanliang;
- Mao, Lili;
- Wei, Xiaoting;
- Sheng, Xinan;
- Chi, Zhihong;
- Yan, Xieqiao;
- Tang, Bixia;
- Lian, Bin;
- Wang, Xuan;
- Zhou, Li;
- Li, Siming;
- Kong, Yan;
- Qi, Zhonghui;
- Xu, Huayan;
- Duan, Rong;
- Guo, Jun;
- Si, Lu
Publication type:
Article
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical Trials.
Published in:
Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.691032
By:
- Zhou, Li;
- Wang, Xuan;
- Chi, Zhihong;
- Sheng, Xinan;
- Kong, Yan;
- Mao, Lili;
- Lian, Bin;
- Tang, Bixia;
- Yan, Xieqiao;
- Bai, Xue;
- Li, Siming;
- Guo, Jun;
- Cui, Chuanliang;
- Si, Lu
Publication type:
Article
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma.
Published in:
International Journal of Cancer, 2007, v. 120, n. 11, p. 2418, doi. 10.1002/ijc.22551
By:
- Guo, Jun;
- Zhu, Jun;
- Sheng, Xinan;
- Wang, Xiaopei;
- Qu, Li;
- Han, Yan;
- Liu, Yuexiang;
- Zhang, Hui;
- Huo, Ling;
- Zhang, Shuhui;
- Lin, Baohe;
- Yang, Zhi
Publication type:
Article
Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.
Published in:
Thoracic Cancer, 2019, v. 10, n. 4, p. 950, doi. 10.1111/1759-7714.13034
By:
- Wang, Xuan;
- Kong, Yan;
- Chi, Zhihong;
- Sheng, Xinan;
- Cui, Chuanliang;
- Mao, Lili;
- Lian, Bin;
- Tang, Bixia;
- Yan, Xieqiao;
- Si, Lu;
- Guo, Jun
Publication type:
Article
First‐line programmed death receptor‐1 (PD‐1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum‐based chemotherapy, for stage IV penile cancer.
Published in:
BJU International, 2023, v. 131, n. 2, p. 198, doi. 10.1111/bju.15828
By:
- Yan, Ru;
- Ma, Huali;
- Jiang, Lijuan;
- Guo, Shengjie;
- Shi, Yanxia;
- Sheng, Xinan;
- Zhang, Yijun;
- Spiess, Philippe E.;
- Liu, Tingyu;
- Xue, Ting;
- Chen, Xiaofeng;
- Li, Zhiyong;
- An, Xin;
- Yao, Kai;
- Zhou, Fangjian;
- Han, Hui
Publication type:
Article
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
Published in:
Cell Death & Disease, 2019, v. 10, n. 4, p. 1, doi. 10.1038/s41419-019-1488-2
By:
- Yu, Sifan;
- Dai, Jie;
- Ma, Meng;
- Xu, Tianxiao;
- Kong, Yan;
- Cui, Chuanliang;
- Chi, Zhihong;
- Si, Lu;
- Tang, Huan;
- Yang, Lu;
- Sheng, Xinan;
- Guo, Jun
Publication type:
Article
Phase Ib study of anlotinib in combination with anti‐PD‐L1 antibody (TQB2450) in patients with advanced acral melanoma.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 1, p. 93, doi. 10.1111/jdv.19467
By:
- Du, Yu;
- Dai, Jie;
- Mao, Lili;
- Wei, Xiaoting;
- Bai, Xue;
- Chen, Ling;
- Lin, Jing;
- Chi, Zhihong;
- Cui, Chuanliang;
- Sheng, Xinan;
- Lian, Bin;
- Tang, Bixia;
- Wang, Xuan;
- Yan, Xieqiao;
- Li, Siming;
- Zhou, Li;
- Guo, Jun;
- Chen, Yu;
- Si, Lu
Publication type:
Article
Phase I study of the recombinant humanized anti-HER2 monoclonal antibody–MMAE conjugate RC48-ADC in patients with HER2-positive advanced solid tumors.
Published in:
Gastric Cancer, 2021, v. 24, n. 4, p. 913, doi. 10.1007/s10120-021-01168-7
By:
- Xu, Yingying;
- Wang, Yakun;
- Gong, Jifang;
- Zhang, Xiaotian;
- Peng, Zhi;
- Sheng, Xinan;
- Mao, Chenyu;
- Fan, Qingxia;
- Bai, Yuxian;
- Ba, Yi;
- Jiang, Da;
- Yang, Fen;
- Qi, Changsong;
- Li, Jian;
- Wang, Xicheng;
- Zhou, Jun;
- Lu, Ming;
- Cao, Yanshuo;
- Yuan, Jiajia;
- Liu, Dan
Publication type:
Article
ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy (Adv. Healthcare Mater. 21/2023).
Published in:
Advanced Healthcare Materials, 2023, v. 12, n. 21, p. 1, doi. 10.1002/adhm.202370121
By:
- Mo, Wenjing;
- Liu, Shujie;
- Zhao, Xiaozhi;
- Wei, Fayun;
- Li, Yuhang;
- Sheng, Xinan;
- Cao, Wenmin;
- Ding, Meng;
- Zhang, Wenlong;
- Chen, Xiaoqing;
- Meng, Longxiyu;
- Yao, Sheng;
- Diao, Wenli;
- Wei, Hui;
- Guo, Hongqian
Publication type:
Article
ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy.
Published in:
Advanced Healthcare Materials, 2023, v. 12, n. 21, p. 1, doi. 10.1002/adhm.202300191
By:
- Mo, Wenjing;
- Liu, Shujie;
- Zhao, Xiaozhi;
- Wei, Fayun;
- Li, Yuhang;
- Sheng, Xinan;
- Cao, Wenmin;
- Ding, Meng;
- Zhang, Wenlong;
- Chen, Xiaoqing;
- Meng, Longxiyu;
- Yao, Sheng;
- Diao, Wenli;
- Wei, Hui;
- Guo, Hongqian
Publication type:
Article
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study.
Published in:
2022
By:
- Zhou, Li;
- Wu, Xiaowen;
- Chi, Zhihong;
- Si, Lu;
- Sheng, Xinan;
- Kong, Yan;
- Mao, Lili;
- Lian, Bin;
- Tang, Bixia;
- Yan, Xieqiao;
- Wang, Xuan;
- Bai, Xue;
- Li, Siming;
- Wei, Xiaoting;
- Li, Juan;
- Yang, Qing;
- Guo, Jun;
- Cui, Chuanliang
Publication type:
journal article
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese Population.
Published in:
Oncologist, 2023, v. 28, n. 8, p. e617, doi. 10.1093/oncolo/oyad070
By:
- Zhou, Li;
- Shao, Zhiting;
- Liu, Yiqiang;
- Yan, Xieqiao;
- Li, Juan;
- Wu, Xiaowen;
- Tang, Bixia;
- Li, Siming;
- Cui, Chuanliang;
- Chi, Zhihong;
- Si, Lu;
- Kong, Yan;
- Mao, Lili;
- Lian, Bin;
- Wang, Xuan;
- Bai, Xue;
- Dai, Jie;
- Guo, Jun;
- Sheng, Xinan
Publication type:
Article
Clinical significance of BRAF<sup>V600E</sup> mutation in circulating tumor DNA in Chinese patients with melanoma.
Published in:
Oncology Letters, 2018, v. 15, n. 2, p. 1839, doi. 10.3892/ol.2017.7529
By:
- Tang, Huan;
- Kong, Yan;
- Si, Lu;
- Cui, Chuanliang;
- Sheng, Xinan;
- Chi, Zhihong;
- Dai, Jie;
- Yu, Sifan;
- Ma, Meng;
- Wu, Xiaowen;
- Yu, Jiayi;
- Xu, Tianxiao;
- Yu, Huan;
- Yan, Junya;
- Guo, Jun
Publication type:
Article
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma.
Published in:
Oncology Letters, 2017, v. 14, n. 3, p. 3601, doi. 10.3892/ol.2017.6608
By:
- Xiaowen Wu;
- Junya Yan;
- Jie Dai;
- Meng Ma;
- Huan Tang;
- Jiayi Yu;
- Tianxiao Xu;
- Huan Yu;
- Lu Si;
- Zhihong Chi;
- Xinan Sheng;
- Chuanliang Cui;
- Yan Kong;
- Jun Guo
Publication type:
Article
Proliferation Marker Ki67 as a Stratification Index of Adjuvant Chemotherapy for Resectable Mucosal Melanoma.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.895672
By:
- Tang, Lirui;
- Wei, Xiaoting;
- Li, Caili;
- Dai, Jie;
- Bai, Xue;
- Mao, Lili;
- Chi, Zhihong;
- Cui, Chuanliang;
- Lian, Bin;
- Tang, Bixia;
- Du, Yu;
- Wang, Xuan;
- Lai, Yumei;
- Sheng, Xinan;
- Yan, Xieqiao;
- Li, Siming;
- Zhou, Li;
- Kong, Yan;
- Li, Zhongwu;
- Si, Lu
Publication type:
Article
The Values of Systemic Immune-Inflammation Index and Neutrophil–Lymphocyte Ratio in Predicting Biochemical Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.907625
By:
- Wang, Shuo;
- Yang, Xiao;
- Yu, Ziyi;
- Du, Peng;
- Sheng, Xinan;
- Cao, Yudong;
- Yan, Xieqiao;
- Ma, Jinchao;
- Yang, Yong
Publication type:
Article
TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma.
Published in:
OncoTargets & Therapy, 2018, v. 11, p. 4097, doi. 10.2147/OTT.S158239
By:
- Yu, Sifan;
- Xu, Tianxiao;
- Dai, Jie;
- Ma, Meng;
- Tang, Huan;
- Chi, Zhihong;
- Si, Lu;
- Cui, Chuanliang;
- Sheng, Xinan;
- Kong, Yan;
- Guo, Jun
Publication type:
Article
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.
Published in:
BMC Cancer, 2014, v. 14, n. 1, p. 858, doi. 10.1186/1471-2407-14-376
By:
- Siming Li;
- Yan Kong;
- Lu Si;
- Zhihong Chi;
- Chuanliang Cui;
- Xinan Sheng;
- Jun Guo
Publication type:
Article
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.
Published in:
BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-376
By:
- Siming Li;
- Yan Kong;
- Lu Si;
- Zhihong Chi;
- Chuanliang Cui;
- Xinan Sheng;
- Jun Guo
Publication type:
Article
High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis.
Published in:
Cancer Science, 2018, v. 109, n. 6, p. 1787, doi. 10.1111/cas.13607
By:
- Xu, Tianxiao;
- Ma, Meng;
- Chi, Zhihong;
- Si, Lu;
- Sheng, Xinan;
- Cui, Chuanliang;
- Dai, Jie;
- Yu, Sifan;
- Yan, Junya;
- Yu, Huan;
- Wu, Xiaowen;
- Tang, Huan;
- Yu, Jiayi;
- Kong, Yan;
- Guo, Jun
Publication type:
Article
The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies.
Published in:
Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.546604
By:
- Wang, Xuan;
- Ji, Qing;
- Yan, Xieqiao;
- Lian, Bin;
- Si, Lu;
- Chi, Zhihong;
- Sheng, Xinan;
- Kong, Yan;
- Mao, Lili;
- Bai, Xue;
- Tang, Bixia;
- Li, Siming;
- Zhou, Li;
- Cui, Chuanliang;
- Guo, Jun
Publication type:
Article
Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma.
Published in:
2014
By:
- Li, Siming;
- Kong, Yan;
- Si, Lu;
- Chi, Zhihong;
- Cui, Chuanliang;
- Sheng, Xinan;
- Guo, Jun
Publication type:
journal article
Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases.
Published in:
BMC Cancer, 2011, v. 11, n. 1, p. 85, doi. 10.1186/1471-2407-11-85
By:
- Zhihong Chi;
- Siming Li;
- Xinan Sheng;
- Lu Si;
- Chuanliang Cui;
- Mei Han;
- Jun Guo
Publication type:
Article

Found: 43